Gnrh antagonists viii
CA 1302650 C · Owner: The Salk Institute For Biological Studies · Inventors: Vale, Wylie W. Jr.; Rivier, Jean E.F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
GnRH ANTAGONISTS VII, ABSTRACT OF THE DISCLOSURE Peptides which inhibit the secretion of gonadotropins by the pituitary gland and inhibit the release of steroids by the gonads. Administration of an effective amount prevents ovulation of female mammalian eggs and/or the release of steroids by the gonads. The peptides have the structure: X-R1-(W)D-Phe-R3-R4- R5-R6-R7-Arg-Pro-R10 wherein X is hydrogen or an acyl group having 7 or less carbon atoms; R1 is dehydro-Pro, D-pGlu, D-Phe, 4Cl-D-Phe, D-Trp Pro, or, B-D-NAL; W is Cl, F, NO2, C?Me/4Cl Cl2 or Br; R3, is D-3PAL, B-D-NAL or (Y)D-Trp with Y being H, NO2, NH2, OCH3, F, Cl, Br CH3, NinFor or NinAc;, R4 is Ser, Orn, AAL or aBu; R5 is Tyr Arg, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted June 2, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 2, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.